Hogan Lovells logo
  • Our people
  • What we do
    Sectors Practices Legal Tech
    • Our sector offering
    • Aerospace and Defense
    • Automotive and Mobility
    • Consumer
    • Education
    • Energy
    • Financial Institutions
    • Insurance
    • Life Sciences and Health Care
    • Manufacturing and Industrials
    • Private Capital
    • Real Estate
    • Sports, Media and Entertainment
    • Technology
    • Transportation and Logistics
    • Corporate & Finance
    • Disputes
    • Global Regulatory
    • Intellectual Property
  • Case studies
  • Our thinking
    • All Our thinking
    • Comparative guides
    • Digital Client Solutions
    • Events and webinars
    • Podcasts
    Insights and Analysis image_2

    AI-washing – when AI hype becomes a litigation risk

  • ESG
  • Careers
Search Search
close
Search Search Search
lang-sel-icon English
  • Deutsch
  • English
  • Español
  • Français
  • 日本語
  • 中文
False
people-new
Mobile area
  • About us
    • Our difference
    • Global management team
  • Where we are
    • Our locations
    • Law Firm Network
  • Media center
    • Media contacts
    • Press releases
    • Awards & rankings
  • Responsible Business
  • HL Inclusion
  • Alumni
LinkedIn
Youtube
twitter
Wechat
Hogan Lovells Our thinking banner ""

Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.
Back to Our thinking
Topics
Countries
Language
Date
Clear
"{0}"

    Insights and Analysis

    FDA one-day inspections pilot: What to expect and how to prepare
    27 May 2026

    Insights and Analysis

    Navigating automation, robotics, AI, and data in a QMSR-driven manufacturing world
    11 May 2026

    News

    Q1/ 2026 - Life Sciences Law Update
    04 May 2026

    News

    Medical devices incorporating AI – Navigating roles and responsibilities of manufacturers/providers and users/deployers under the MDR and AIA
    30 April 2026

    Insights and Analysis

    China’s medical insurance enforcement in 2026: New rules, active campaign, and implications for pharmaceutical companies
    24 April 2026

    Insights and Analysis

    EU Rethinks How to Regulate AI in Medical Devices – Interplay between the MDR and AIA under current and proposed legislation
    24 April 2026

    News

    EU Design Act: Designing the future - why the EU Design Act matters for medical devices
    07 April 2026

    News

    FTC launches task force to promote competition and consumer protection enforcement in the healthcare industry
    24 March 2026

    News

    A new “tax” on medical device manufacturers and distributors? The Italian Council of State questions the constitutional legitimacy of the Medical Device Governance Fund
    16 March 2026

    Insights and Analysis

    Bundling’s other test: When AKS-friendly discounts create antitrust risk
    09 March 2026

    No results found

    Load more

    "" ""
    Digital Client Solutions
    Empowering you to lead change through our digital solutions.
    Learn more
    Hogan Lovells logo
    Contact us
    Quick Links
    • About us
    • Where we are
    • Media center
    • Responsible Business
    • HL Inclusion
    • Alumni
    • Contact us
    • Cookies
    • Disclaimer
    • Fraudulent and Scam Emails
    • Legal notices
    • Modern Slavery Statement
    • Our thinking terms of use
    • Privacy
    • RSS
    Connect with us
    LinkedIn
    Youtube
    Twitter
    Wechat

    © 2026 Hogan Lovells. All rights reserved. "Hogan Lovells" or the “firm” refers to the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses, each of which is a separate legal entity. Attorney advertising. Prior results do not guarantee a similar outcome.

    Subscribe to Our thinking
    Connect with us
    LinkedIn
    Youtube
    Twitter
    Wechat